Biotechnology News

WATERTOWN, Mass., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...

Company Announcement COPENHAGEN, Denmark; October 28, 2026 Phase 3 LiGeR-HN1 trial of Petosemtamab in combination with pembrolizumab versus pembrolizumab alone met both primary endpoints, reducing...

Applied Biologics announces peer-reviewed publication of CAMPX interim results in CWCMR.

Longeveron announces it has retained Lucid Capital Markets as the Company’s financial advisor to explore potential strategic opportunities.

Biosphere secures $21M Department of War contract to scale domestic biomanufacturing of critical chemicals and reduce reliance on foreign supply chains

WALNUT CREEK, Calif. and SAN FRANCISCO, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Manta Cares, a San Francisco company that builds AI for people with cancer and their families, and Cancer Support...

Rob Scott, MD has been appointed to the Arcutis Board of Directors effective October 23, 2026. Dr. Scott is a global pharma industry leader and pioneer.

SYDNEY, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that following formal achievement of database lock in its pivotal XanaMIA trial of oral Xanamem® in...

MILAN and MORRISTOWN, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel...

DURHAM, N.C., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Scipher Medicine (Scipher), a leader in immunology precision medicine, today announced the expected launch of an early physician access program for...